Evidence

Our programmes are designed by medical professionals and are backed up by clinical studies that prove the efficacy of our chosen treatment paths.

The effects of treatment with liraglutide on quality of life and depression in young obese women with PCOS and controls

The role of GLP-1 receptor agonists as weight loss agents in patients with and without type 2 diabetes

Semaglutide as a promising antiobesity drug

Role of glucagon-like peptide 1 receptor agonists in management of obesity

Efficacy of High-Dose Liraglutide as an Adjunct for Weight Loss in Patients with Prior Bariatric Surgery

Reversal of Long-Term Weight Regain After Roux-en-Y Gastric Bypass Using Liraglutide or Surgical Revision. A Prospective Study

Liraglutide and obesity: a review of the data so far

Liraglutide: A Review of Its Use in the Management of Obesity

Liraglutide: A New Option for the Treatment of Obesity

Liraglutide increases IVF pregnancy rates in obese PCOS women with poor response to first-line reproductive treatments: a pilot randomized study

What are the effects of once‐daily Liraglutide when used to treat obesity?

What are the effects of once‐weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity?